News from ampio pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 23, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the opening of its new headquarters, manufacturing and research facility: Ampio...

Jun 30, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Initiates Study of Multiple Injections of Ampion™ Into the Knees of Patients with OA of the Knee to Assess its Healing and Cartilage Regeneration Effects

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has started patient enrollment for the MULTIPLE INJECTIONS STUDY using...

Jun 25, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals, in Response to Positive Feedback, Closes Enrollment in the OptimEyes Study (Optina™) and Will Present the Data to the FDA for Guidance

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has informed the Transplant and Ophthalmology Division of the FDA of its...

Jun 05, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals Announces Appointment of Gregory A. Gould as Chief Financial Officer

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the appointment of Gregory A. Gould as Chief Financial Officer, Treasurer, and...

May 21, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals to present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3rd at 8:30 AM

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present a corporate update at the Jefferies...

Apr 21, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

 Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE) today announced that its wholly-owned subsidiary Vyrix Pharmaceuticals has filed a registration...

Apr 10, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane™ in Canada and Other Territories to Broaden its International Footprint

Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE) today announced that its wholly-owned subsidiary Vyrix Pharmaceuticals, a specialty pharmaceutical...

Apr 09, 2014, 08:07 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Results from the 20 weeks extension of the Ampion™ SPRING study to be presented at the Western Orthopedic Association Conference

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the results of the 20 weeks extension of the Ampion™ SPRING study will be...

Mar 11, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Announces Investor call Thursday March 13, 4 PM EDT.

Ampio Announces Investor call Thursday March 13, 4 PM EDT. /* Style Definitions...

Mar 05, 2014, 10:53 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals, Inc. Closes Sale Of 9,775,000 Shares Of Common Stock

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the closing of its sale of 9,775,000 shares of common stock in an underwritten public...

Feb 27, 2014, 20:01 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 8,500,000 Shares Of Common Stock

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has priced an underwritten public offering of 8,500,000 shares of its common...

Feb 24, 2014, 07:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals, Inc. Announces Public Offering of Common Stock

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it intends to offer 8,000,000 shares of its common stock in a proposed...

Feb 18, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Completes Enrollment and Dosing in 2nd Pivotal Clinical Trial for Ampion™ (The STEP Study) for Its FDA Biological License Application (BLA)

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it has completed enrollment and dosing of 500 patient in the pivotal trial of...

Feb 13, 2014, 06:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Announces Positive Preliminary Biochemical Findings from the Synovial Fluid of the Knees Treated in the SPRING Study

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced preliminary biochemical analysis of samples of synovial fluid drawn from the...

Feb 04, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals announces publication of findings for its lead product, Ampion™ in the journal PLOS ONE

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ("Ampio" or the "Company") today announced that the article reporting the results of its initial...

Jan 15, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals Breaks Ground on Construction of Ampion™ Manufacturing Facility

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) held a groundbreaking ceremony on Friday, January 10th to announce the start of construction of...

Jan 13, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Injects First Patients in 2nd Phase III, Pivotal Clinical Trial for Ampion™(The STEP Study) for Its FDA Biological License Application (BLA).

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the 500 patient Phase III pivotal trial of AmpionTM for the treatment for...

Jan 09, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Luoxis Awarded ISO 13485:2003 and ISO 9001:2008 Certifications

 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that subsidiary Luoxis has received ISO 13485:2003 certification, an...

Jan 06, 2014, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Luoxis Establishes Study Collaborations with Two Research Centers in Oxidative Stress

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that subsidiary Luoxis has entered into research agreements with Western Galilee...

Dec 16, 2013, 08:00 ET
Ampio Pharmaceuticals Logo.  (PRNewsFoto/Ampio Pharmaceuticals, Inc.)

Ampio Pharmaceuticals Leases New Facility in Denver Tech Center

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the ten-year lease of a multi-purpose facility located in the Denver Tech Center of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge